Evaluating movement disorders in pediatric patients receiving risperidone: a comparison of spontaneous reports and research criteria for TD
Open Access
- 26 June 2007
- journal article
- Published by Springer Nature in Child and Adolescent Psychiatry and Mental Health
- Vol. 1 (1) , 3
Abstract
Movement disorders (MD) in children are relatively common and may be associated with medication use. Objective methods (ie rating scales) and specific research criteria may be helpful in identifying MD-related adverse events that would otherwise not be apparent from spontaneous reports. We assessed whether more stringent and rigorous criteria would provide MD rates similar to those derived subjectively from spontaneous reports.Keywords
This publication has 30 references indexed in Scilit:
- Long-Term Use of Risperidone in Children with Disruptive Behavior Disorders and Subaverage Intelligence: Efficacy, Safety, and TolerabilityJournal of Child and Adolescent Psychopharmacology, 2006
- A Randomized, Double-Blind, Placebo-Controlled Study of Risperidone Maintenance Treatment in Children and Adolescents With Disruptive Behavior DisordersAmerican Journal of Psychiatry, 2006
- Long-term safety and efficacy of risperidone in children with disruptive behaviour disordersEuropean Child & Adolescent Psychiatry, 2006
- An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: Results from a long-term studySchizophrenia Research, 2005
- Risperidone Treatment of Autistic Disorder: Longer-Term Benefits and Blinded Discontinuation After 6 MonthsAmerican Journal of Psychiatry, 2005
- Long-Term, Open-Label Study of Risperidone in Children With Severe Disruptive Behaviors and Below-Average IQAmerican Journal of Psychiatry, 2004
- Movement Disorders in ChildrenPediatrics in Review, 2003
- Double-Blind, Placebo-Controlled Study of Risperidone for the Treatment of Disruptive Behaviors in Children With Subaverage IntelligenceAmerican Journal of Psychiatry, 2002
- Methodological Issues in Designing a Multisite Trial of Risperidone in Children and Adolescents with AutismJournal of Child and Adolescent Psychopharmacology, 2001
- The Nisonger CBRF: A child behavior rating form for children with developmental disabilitiesResearch in Developmental Disabilities, 1996